News
Please enjoy the latest industry news aggregated from top Life Sciences sources including BioPharma Dive, FierceBiotech and STAT.
- STAT+: Biogen drug for rare form of ALS fails pivotal study — another setback for fatal disease with few treatments
- Opinion: Historic yet imperfect: Malaria vaccine brings hope but the fight is far from over
- Johnson & Johnson wins FDA panel backing for a second dose of its COVID shot but don’t call it a ‘booster’
- FDA panel endorses second shot for adults who received J&J vaccine
- FDA advisory panel votes 19-0 to endorse booster dose of J&J vaccine
- Agenus cell therapy spin-off MiNK inks mark on Wall Street with low-end $40M IPO
- AstraZeneca immunotherapy combo extends survival in liver cancer trial
- Biden reportedly weighing former FDA chief Califf to again lead agency
- NIH deals out $77.7M to develop 12 new rapid COVID diagnostics from BD, Quidel and more
- Roche welcomes PathAI into its open digital pathology initiative
- Bayer, CureVac part ways on COVID-19 vaccine: reports
- STAT+: Up and down the ladder: The latest comings and goings
- Despite Merck's oral COVID-19 drug, antibodies by Regeneron, GSK and others still have billions in sales ahead: analyst
- Greenwood takes the top job at Kojin Therapeutics, leading an all-woman biotech C-suite
- FDA adds Class I recall label to Abbott Alinity COVID tests after risk of false positives